Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 3
1972 4
1973 1
1974 1
1975 1
1976 1
1977 1
1978 1
1979 3
1980 2
1981 1
1982 1
1983 2
1984 3
1985 2
1986 1
1987 1
1989 1
1991 1
1993 2
1995 1
1996 1
1997 1
1998 1
1999 2
2000 1
2002 1
2003 1
2004 1
2005 1
2006 1
2007 1
2008 1
2009 1
2010 3
2011 4
2012 7
2013 5
2015 1
2016 1
2017 7
2018 2
2019 2
2020 2
2021 2
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

81 results
Results by year
Filters applied: . Clear all
Page 1
Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment.
Georgouli M, Herraiz C, Crosas-Molist E, Fanshawe B, Maiques O, Perdrix A, Pandya P, Rodriguez-Hernandez I, Ilieva KM, Cantelli G, Karagiannis P, Mele S, Lam H, Josephs DH, Matias-Guiu X, Marti RM, Nestle FO, Orgaz JL, Malanchi I, Fruhwirth GO, Karagiannis SN, Sanz-Moreno V. Georgouli M, et al. Among authors: perdrix a. Cell. 2019 Feb 7;176(4):757-774.e23. doi: 10.1016/j.cell.2018.12.038. Epub 2019 Jan 31. Cell. 2019. PMID: 30712866 Free PMC article.
[ICSI treatment in severe asthenozoospermia].
Mitchell V, Sigala J, Jumeau F, Ballot C, Peers MC, Decanter C, Rives N, Perdrix A, Rigot JM, Escalier D. Mitchell V, et al. Among authors: perdrix a. Gynecol Obstet Fertil. 2012 Dec;40(12):776-9. doi: 10.1016/j.gyobfe.2012.10.003. Epub 2012 Nov 20. Gynecol Obstet Fertil. 2012. PMID: 23182233 Review. French.
[Assisted reproductive technologies with sperm donation].
Rives N, Sibert L, Perdrix A, Hennebicq S, Julliard JC; la Fédération française des CECOS. Rives N, et al. Among authors: perdrix a. Prog Urol. 2012 Sep;22(10):561-7. doi: 10.1016/j.purol.2012.04.014. Epub 2012 May 31. Prog Urol. 2012. PMID: 22920333 Review. French.
Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer.
Clatot F, Perdrix A, Beaussire L, Lequesne J, Lévy C, Emile G, Bubenheim M, Lacaille S, Calbrix C, Augusto L, Guillemet C, Alexandru C, Fontanilles M, Sefrioui D, Burel L, Guénot S, Richard D, Sarafan-Vasseur N, Di Fiore F. Clatot F, et al. Among authors: perdrix a. Breast Cancer Res. 2020 May 28;22(1):56. doi: 10.1186/s13058-020-01290-x. Breast Cancer Res. 2020. PMID: 32466779 Free PMC article.
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC).
Sefrioui D, Beaussire L, Gillibert A, Blanchard F, Toure E, Bazille C, Perdrix A, Ziegler F, Gangloff A, Hassine M, Elie C, Bignon AL, Parzy A, Gomez P, Thill C, Clatot F, Sabourin JC, Frebourg T, Benichou J, Bouhier-Leporrier K, Gallais MP, Sarafan-Vasseur N, Michel P, Di Fiore F. Sefrioui D, et al. Among authors: perdrix a. Br J Cancer. 2021 Aug;125(5):725-733. doi: 10.1038/s41416-021-01431-9. Epub 2021 Jun 10. Br J Cancer. 2021. PMID: 34112948 Free PMC article.
81 results